References
- Benecke JEJr. Facial paralysis. Otolaryngol Clin North Am 2002;35:357–65.
- Kobayashi M, Costanzo RM. Olfactory nerve recovery following mild and severe injury and the efficacy of dexamethasone treatment. Chem Senses 2009;34:573–80.
- Drew PD, Chavis JA. Inhibition of microglial cell activation by cortisol. Brain Res Bull 2000;52:391–6.
- Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids--new mechanisms for old drugs. N Engl J Med 2005;353:1711–23.
- Hall ED. The effects of glucocorticoid and nonglucocorticoid steroids on acute neuronal degeneration. Adv Neurol 1993;59:241–8.
- Zhu TS, Glaser M. Neuroprotection and enhancement of remyelination by estradiol and dexamethasone in cocultures of rat DRG neurons and Schwann cells. Brain Res 2008;1206:20–32.
- Chrousos GA, Kattah JC, Beck RW, Cleary PA. Side effects of glucocorticoid treatment. Experience of the Optic Neuritis Treatment Trial. JAMA 1993;269:2110–12.
- Mohammadi R, Azad-Tirgan M, Amini K. Dexamethasone topically accelerates peripheral nerve repair and target organ reinnervation: a transected sciatic nerve model in rat. Injury 2013;44:565–9.
- Hosny KM. Preparation and evaluation of thermosensitive liposomal hydrogel for enhanced transcorneal permeation of ofloxacin. AAPS PharmSciTech 2009;10:1336–42.
- Chenite A, Chaput C, Wang D, Combes C, Buschmann MD, Hoemann CD, et al. Novel injectable neutral solutions of chitosan form biodegradable gels in situ. Biomaterials 2000;21:2155–61.
- Ruel-Gariepy E, Chenite A, Chaput C, Guirguis S, Leroux J. Characterization of thermosensitive chitosan gels for the sustained delivery of drugs. Int J Pharm 2000;203:89–98.
- Xu L, Heldrich J, Wang H, Yamashita T, Miyamoto S, Li A, et al. A controlled and sustained local gentamicin delivery system for inner ear applications. Otol Neurotol 2010;31:1115–21.
- Burgette RC, Benscoter BJ, Monaco GN, Kircher ML, Mantravadi AV, Marzo SJ, et al. A rat model for intracranial facial nerve crush injuries. Otolaryngol Head Neck Surg 2012;146:326–30.
- Sunderland S. A classification of peripheral nerve injuries producing loss of function. Brain 1951;74:491–516.
- Ruel-Gariepy E, Shive M, Bichara A, Berrada M, Le Garrec D, Chenite A, et al. A thermosensitive chitosan-based hydrogel for the local delivery of paclitaxel. Eur J Pharm Biopharm 2004;57:53–63.
- Taskale P, Topaloglu I. [The healing effects of vitamin E with corticosteroid and vitamin E alone on nerve healing in rats with traumatic facial palsy]. Kulak Burun Bogaz Ihtis Derg 2010;20:255–9.
- Chen LJ, Ren YH, Liu L, Zhang XQ, Zhao Y, Wu WT, et al. Upregulated expression of GAP-43 mRNA and protein in anterior horn motoneurons of the spinal cord after brachial plexus injury. Arch Med Res 2010;41:513–18.
- Zhang W, Miao Y, Xing Z, Li H, Liu H, Li Z. Growth-associated protein-43 expression in cocultures of dorsal root ganglion neurons and skeletal muscle cells with different neurotrophins. Muscle Nerve 2013;47:909–15.
- Yao GL, Kiyama H. Dexamethasone enhances level of GAP-43 mRNA after nerve injury and facilitates re-projection of the hypoglossal nerve. Brain Res Mol Brain Res 1995;32:308–12.